Journal of Commerce and Accounting Research

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Comparison of Profitability of Listed Pharmaceutical Companies of Bangladesh


Affiliations
1 Department of Accounting and Information Systems, University of Chittagong., Bangladesh
2 Chittagong University of Engineering & Technology (CUET)., Bangladesh
3 Department of Management Studies Premier University., Bangladesh
     

   Subscribe/Renew Journal


Pharmaceutical industry is technologically the most advanced manufacturing industry in Bangladesh and the third largest industry in terms of contribution to government's revenue. The industry contributes about 1% of the total GDP. There are about 250 licensed pharmaceutical companies in Bangladesh. Currently a little over 100 companies are in production. According to IMS, a US-based market research firm, the retail market size is about BDT 84 billion as on 2011. Based on IMS report for the fourth quarter 2011, Square pharmaceutical holds the top market share in the retail market (18.7%), followed by Incepta and Beximco pharmaceutical. This sector fulfills 97% of the local medicine requirement. Besides, it is exporting chemicals and pharmaceutical products to global market including European market. The professional think tank, quality management, innovative ideas, government support are the key factors for the development of this sector. Hence the present study reports the profitability of two listed pharmaceutical companies of four year accounting period from 2008 to 2011. The analysis shows that average profitability indicators for Square are higher than Beximco, except gross profit ratio and operating profit ratio. On the other hand, the six other profitability indicators of Square are much higher than that of Beximco and go with the industry norm. Beximco has not been able to attain industry average net profit ratio, return on investment and return on equity, cash flow margin and cash return on assets.

Keywords

Profit, Profitability Indicators, Square And Beximco Pharmaceutical Industry
Subscription Login to verify subscription
User
Notifications
Font Size


  • Bagozzi, R. P. & Yi, Y. (1988). On the evaluation of structural equation models. Journal of the Academy of Marketing Science, 16(1), 74-95.

  • Barr, K. (2008). Analyzing financial information using ratios. Retrieved from http://www.nonprofitsassistancefund. org/clientuploads/MNAF

  • Beximco Pharmaceutical Company Ltd. (2008-2011). Annual Report.

  • Collier, H. W., Grai, T., Haslitt, S. C. & McGowan, B. (2004), An example of the use of financial ratio analysis: The case of Motorola. Retrieved from http://ro.uow.edu. au/cgi/viewcontent.cgi/article=1025

  • Iyer, N. (1995). An evaluation of the financial performance of public sector enterprises of Kerala. (Unpublished doctoral dissertation). Kerala: University of Kerala.

  • Jahur, M. S., Parveen, J. A. (1996). An analysis of financial performance of public enterprises-a case study of chittagong steel mills ltd.", Chittagong University Journal of commerce, 12, 173-184.

  • Lieberman, M. & Hall, R. E. (2005). How Firms Make Decisions: Profit Maximization (2nded.). Introduction to Economics.

  • Lyles, M. A., Baird, S. I., Orris, J. B. & Kuratko, D. F. (1993). Formalized planning in small business: Increased strategic choices. Journal of Small Business Management, 1, 38-50.

  • Mohsin, M. (1970). Financial planning and control (pp. 174). New Delhi: Vikas Publishing House Pvt. Ltd.

  • Nimalathasan, B. (2009). Profitability of listed pharmaceutical companies in Bangladesh: An inter & intra comparison of Ambee & IBN Sina companies. Annals of University of Bucharest, Economic and Administrative Series, 3(1), 139-148.

  • Pandey, I. M. (1979). Financial management (pp. 443). New Delhi: Vikas Publishinng House Pvt. Ltd.

  • Rubin, H. P. (2012). A tutorial for the president on profit maximization. Wall Street Journal. Retrieved from http://online.wsj.com

  • Salauddin, A. (2001). Profitability of pharmaceutical companies of Bangladesh. The Chittagong University Journal of Commerce, 16, 54-64.

  • Schmalessee, R. (1987). Collusion versus differential efficiency: Testing alternative hypothesis. Journal of Industrial Economics, 35(4), 399-425.

  • Scherer, F. M. (2001). The link between Gross Profitability and Pharmaceutical Spending. Health Affairs, 20(5), 216-220.

  • Sina, M. A. & Matubber, M. A. (1998) .Financial statement analysis of khulna newsprint mills ltd. Islamic University Studies, 1, 211-223.

  • Square Pharmaceuticals Ltd. (2008-2011). Annual Report.

  • Velnampy, T. & Nimalathasan B. (2007). Organizational growth and profitability: a case study analysis of bank of Ceylon. Journal of Business Studies, 3, 224-235.

  • Velnampy, T. (2005). A study on investment appraisal and profitability. Journal of Business Studies, 2(1), 23-35.

  • Venkatraman, N. & Ramanujam, V. (1986). Measurement of business performance in strategy research: A Comparisonof Approaches. Academy of Management Review, 11(4), 801-815.


Abstract Views: 839

PDF Views: 0




  • Comparison of Profitability of Listed Pharmaceutical Companies of Bangladesh

Abstract Views: 839  |  PDF Views: 0

Authors

Mouri Dey
Department of Accounting and Information Systems, University of Chittagong., Bangladesh
Suman Dey
Chittagong University of Engineering & Technology (CUET)., Bangladesh
Sujan Kanti Biswas
Department of Management Studies Premier University., Bangladesh

Abstract


Pharmaceutical industry is technologically the most advanced manufacturing industry in Bangladesh and the third largest industry in terms of contribution to government's revenue. The industry contributes about 1% of the total GDP. There are about 250 licensed pharmaceutical companies in Bangladesh. Currently a little over 100 companies are in production. According to IMS, a US-based market research firm, the retail market size is about BDT 84 billion as on 2011. Based on IMS report for the fourth quarter 2011, Square pharmaceutical holds the top market share in the retail market (18.7%), followed by Incepta and Beximco pharmaceutical. This sector fulfills 97% of the local medicine requirement. Besides, it is exporting chemicals and pharmaceutical products to global market including European market. The professional think tank, quality management, innovative ideas, government support are the key factors for the development of this sector. Hence the present study reports the profitability of two listed pharmaceutical companies of four year accounting period from 2008 to 2011. The analysis shows that average profitability indicators for Square are higher than Beximco, except gross profit ratio and operating profit ratio. On the other hand, the six other profitability indicators of Square are much higher than that of Beximco and go with the industry norm. Beximco has not been able to attain industry average net profit ratio, return on investment and return on equity, cash flow margin and cash return on assets.

Keywords


Profit, Profitability Indicators, Square And Beximco Pharmaceutical Industry

References